EN DE
STOCK COMPARISON

NaviFUS vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how NaviFUS (6872) and Abbott Laboratories (ABT) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: NaviFUS trades at TWD 22.35 versus a fair value of TWD 4.58 (-79%), while Abbott Laboratories trades at $101 versus $74.79 (-26%).
NaviFUS
6872.TWO · TWD · Information Technology
-79%
upside to fair value
overvalued
PriceTWD 22.35
Fair ValueTWD 4.58
Quality28/100
Abbott Laboratories
ABT · USD · Health Care
-26%
upside to fair value
overvalued
Price$101
Fair Value$74.79
Quality66/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

NaviFUSAbbott Laboratories
Valuation
n/aP/E (TTM)28.5×
n/aP/S (TTM)4.01×
0.09×P/B3.47×
n/aEV/EBITDA15.5×
n/aPEG1.47×
−79.5%Fair value upside−26.0%
n/aDividend yield2.4%
n/aDividend per share$2.48
Profitability
0%Operating margin13%
n/aEBIT margin trend (5Y)1.19×
n/aReturn on equity12%
0%Return on assets6%
Growth
0%Revenue growth (YoY)8%
-18.7%Avg. growth/yr (3Y)0.5%
n/aAvg. growth/yr (5Y)5.1%
n/aValue creation/yr+10.6%
Balance & size
n/aInterest coverage (EBIT/interest)23.6×
n/aDebt / equity0.19×
$50MMarket cap$181B
weakGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Abbott Laboratories leads: 0 to 5 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

NaviFUSof which business quality 28 · market factors 51 Abbott Laboratoriesof which business quality 66 · market factors 48
ProfitabilityMargins and returns on capital today
0
50
Quality GrowthAre margins and returns improving?
8
47
CashflowEarnings quality: real cash, not paper profit
3
71
Fin. StrengthBalance sheet, leverage, solvency risk
100
80
InvestmentDisciplined investing over empire-building
48
65
Low VolatilityCalm price path (market factor)
40
84
MomentumPrice trend over the last 3–12 months (market factor)
56
39
52W MomentumDistance to the 52-week high (market factor)
56
23
Net IssuanceShare count: buybacks or dilution?
2
83

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyNaviFUSPrice TWD 22.35Abbott LaboratoriesPrice $101
DCF Modelsn/a-26%below the price$74.80
Earnings-Basedn/a-71%below the price$29.42
Dividend Discountn/a-61%below the price$39.73
Multiplesn/a-30%below the price$70.72
Asset-Based-76%below the priceTWD 5.26-80%below the price$20.05
Growth DCFn/a-32%below the price$68.58
Economic Profitn/a-63%below the price$37.49
Growth Earningsn/a-30%below the price$70.25
Minimum-76%below the priceTWD 5.26-80%below the price$20.05
Maximum-76%below the priceTWD 5.26-26%below the price$74.80
Median-76%below the priceTWD 5.26-46%below the price$54.15
Geometric mean-76%below the priceTWD 5.26-54%below the price$46.64

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

NaviFUS: 1 of 1 models see the stock below the current price.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

NaviFUS
Price TWD 22.35
Fair Value TWD 4.58
Bear TWD 3.02Bull TWD 5.72
Abbott Laboratories
Price $101
Fair Value $74.79
Bear $52.28Bull $94.43

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

NaviFUS · Information Technology

Quality score28 · bottom 25%
Fair value upside-79% · bottom 25%

Abbott Laboratories · Health Care

Quality score66 · Top 25%
Fair value upside-26% · below median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: NaviFUS trades at TWD 22.35 versus a fair value of TWD 4.58 (-79%), while Abbott Laboratories trades at $101 versus $74.79 (-26%).

Abbott Laboratories has the higher quality score (66/100).

Open Abbott Laboratories live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.